MedImmune

  www.medimmune.com
  www.medimmune.com

MedImmune Reviews

197 Reviews
3.6
197 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
MedImmune President Bahija Jallal
Bahija Jallal
40 Ratings
  1.  

    Great place to work, but hard to get promoted

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at MedImmune

    Pros

    Great benefits, modern facility, challenging projects. I enjoy working here, many other people do.

    Cons

    not so sure what to say

    Recommends
    Positive Outlook
    Approves of CEO

MedImmune Interviews

Updated Nov 22, 2014
Updated Nov 22, 2014

Interview Experience

Interview Experience

55%
23%
20%

Getting an Interview

Getting an Interview

70%
13%
6%

Interview Difficulty

2.7
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Training Manager Interview

    Anonymous Employee
    Anonymous Employee
    Interview Details

    It is a typical process: you find the job, and submitted resume online as requested. HR folks will call you and ask a bunch of questions, and they took note of EVERYTHING you said to them and put it in your application profile. Then the hiring manager will call you and talk with you for 30-45 minutes.

    Interview Questions
    • Tell me about what do you do besides your job responsibilities. I certainly heard this before, but as a mid-career professional, I am not sure about what they are asking. It is understandable for a new grad, though.   Answer Question
    No Offer
    Average Interview

MedImmune Awards & Accolades

Something missing? Add an award
Most Admired Companies in Research Science, Black Engineer & Information Technology, 2010

Additional Info

Unlock Profile
Website www.medimmune.com
Headquarters Gaithersburg, MD
Size 5000+ Employees
Founded 1988
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue $1 to $2 billion (USD) per year

MedImmune works to boost the immune systems of babies and grown-ups. Its flagship biotech product, Synagis, prevents respiratory syncytial virus (RSV), a major cause of pneumonia and other respiratory disease in infants and children. Also on the market are FluMist, its nasal spray flu vaccine, and Ethyol, which treats side effects of chemotherapy and radiation. The company is working on dozens of investigational therapies -- including monoclonal antibodies, vaccines, and small molecule drugs -- in the areas of infectious diseases, cancer, and inflammatory conditions... More

Work at MedImmune? Share Your Experiences

MedImmune

 
Click to Rate
or